Fierce Pharma September 18, 2024
Andrea Park

No longer a far-off futuristic idea, artificial intelligence technology has seen its popularity skyrocket in recent years. Its usage continues to grow rapidly and exponentially: According to IBM’s most recent Global AI Adoption Index report, around 42% of large businesses are actively using AI, up from 35% just one year prior and 31% the year before that.

Amid all the AI hype, pharma marketers are taking a more cautious approach to implementing the technology. In interviews with Fierce Pharma Marketing at Fierce’s annual Digital Pharma East event in Philadelphia last week, marketing leaders from Bayer, Daiichi Sankyo and argenx discussed that slower integration of AI as well as the many opportunities for the technology in the realm of pharma marketing.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
Organon makes dermatology play with $1.2bn Dermavant buyout
Inflation Reduction Act: A Battleground for Health Care Policy
Pharma Pulse: 9/18/24: How Drug Shortages Affect Pharmacovigilance, Long Strange Trip Continues for Psychedelics & more
PBM strikes back at FTC over drug pricing report
GLP-1s could prevent 34K strokes, heart attacks annually: Report

Share This Article